NCT06167941
- Conditions
- Expression of Integrin ανβ3 in Lung Cancer
- Locations
-
- Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital Seoul, South Korea
Clinical trial condition
Expression of Integrin ανβ3 in Lung Cancer
Explore clinical trials studying Expression of Integrin ανβ3 in Lung Cancer. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies